Stay updated on BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page.

Latest updates to the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page
- Check4 days agoChange DetectedThe two screenshots show the same study record with minor UI/formatting adjustments; core study content such as arms, eligibility criteria, and outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check33 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference4%

- Check40 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check54 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new medical topics related to cancer and immunotherapy. Several previous terms related to antineoplastic agents and immune checkpoint inhibitors have been removed.SummaryDifference3%

Stay in the know with updates to BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page.